Product Description
Ref-SKU:
006N-03072 Plasmid contains the entire genome of HIV-1 with specific mutations in the viral protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure.
Product Risk Group:
Information on the related virus
ICTV Taxonomy:
Virus name:
Subspecies:
Strain:
Isolate:
Cloned Product: Yes
Special feature:
Can it be used to produce GMO:
No
Biosafety restrictions:
Plasmid contains the entire genome of HIV-1 with specific mutations in the rt gene, which can confer drug resistance to specific RT inhibitors. Might produce infectious virus after transfection into suitable human cells.
Region encompassed in this Product:
entire HIV-1 genome
Plasmid:
Plasmid selection:
TAG:
Sequencing:
Fully sequenced
Sequence controlled:
Yes
Mutations:
No mutation compared to the reference sequence
Storage conditions:
TE Buffer -20C
Shipping conditions:
IATA Classification:
Virus host type:
Previous Name or Taxonomy:
Information about the origin of the product
Recombinant product:
This product is a recombinant product
Biological material origin:
Synthetic origin & Natural origin
Natural part identification: NL4-3
Natural part identification:
NL4-3
Genbank reference:
Collection date: BEFORE
Monday, 26 July, 2021
Country of collection:
Synthetic part identification: amino acid position 82 in the viral protease gene
Synthetic part identification:
amino acid position 82 in the viral protease gene
Modifications from the reference sequence(s):
The sequence(s) of this synthetic product has been modified from the sequence listing provided as Genbank references